Santhera Pharmaceuticals Holding AG has raised CHF 54.8 million (€50.38 million) in a private placement of its shares with investors in Switzerland and abroad to advance its portfolio of specialty medicines led by a treatment for a rare eye disease.
Santhera Pharmaceuticals Holding AG has raised CHF 54.8 million (€50.38 million) in a private placement of its shares with investors in Switzerland and abroad to advance its portfolio of specialty medicines led by a treatment for a rare eye disease.